Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Lidija Kovač & Zdenko Časar. (2020) A literature review of the patent application publications on cabotegravir – an HIV integrase strand transfer inhibitor. Expert Opinion on Therapeutic Patents 30:3, pages 195-208.
Read now
Read now
Hanh Thi Pham & Thibault Mesplède. (2019) Bictegravir in a fixed-dose tablet with emtricitabine and tenofovir alafenamide for the treatment of HIV infection: pharmacology and clinical implications. Expert Opinion on Pharmacotherapy 20:4, pages 385-397.
Read now
Read now
Qiu-Qin He, Xuan Zhang, Liu-Meng Yang, Yong-Tang Zheng & Fener Chen. (2013) Synthesis and biological evaluation of 5-fluoroquinolone-3-carboxylic acids as potential HIV-1 integrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 28:4, pages 671-676.
Read now
Read now
Christine Katlama & Robert Murphy. (2009) Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection. Therapeutics and Clinical Risk Management 5, pages 331-340.
Read now
Read now
Laura MacDonald, Mano Murty & Brian C Foster. (2009) Antiviral drug disposition and natural health products: risk of therapeutic alteration and resistance. Expert Opinion on Drug Metabolism & Toxicology 5:6, pages 563-578.
Read now
Read now
C. Fenollar-Ferrer, V. Carnevale, S. Raugei & P. Carloni. (2008) HIV-1 integrase–DNA interactions investigated by molecular modelling. Computational and Mathematical Methods in Medicine 9:3-4, pages 231-243.
Read now
Read now
Articles from other publishers (42)
Fernanda de Lima Moreira, Tiago Antunes Paz, Patrícia Pereira dos Santos Melli, Matheus de Lucca Thomaz, Maria Paula Marques, Adriana Rocha, Geraldo Duarte & Vera Lucia Lanchote. (2023) Total, Unbound, Renal, and Hepatic Clearances of Raltegravir and the Formation and Elimination Clearances of Raltegravir Glucuronide in Pregnant Women. The Journal of Clinical Pharmacology 63:9, pages 1053-1060.
Crossref
Crossref
Rohan Gurjar, Laura Dickinson, Daniel Carr, Wolfgang Stöhr, Stefano Bonora, Andrew Owen, Antonio D’Avolio, Adam Cursley, Nathalie De Castro, Gerd Fätkenheuer, Linos Vandekerckhove, Giovanni Di Perri, Anton Pozniak, Christine Schwimmer, François Raffi & Marta Boffito. (2022) Influence of UGT1A1 and SLC22A6 polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-study. The Pharmacogenomics Journal 23:1, pages 14-20.
Crossref
Crossref
Mauro De Nisco, Antonio Di Maio, Michele Manfra, Carmine Ostacolo, Alessia Bertamino, Pietro Campiglia, Isabel M. Gomez-Monterrey & Silvana Pedatella. (2022) N-4 Alkyl Cytosine Derivatives Synthesis: A New Approach. Reactions 3:1, pages 192-202.
Crossref
Crossref
David Delgado & Rodrigo Abonia. (2022) Synthetic approaches for BF2-containing adducts of outstanding biological potential. A review. Arabian Journal of Chemistry 15:1, pages 103528.
Crossref
Crossref
Yue Wang, Shuang-Xi Gu, Qiuqin He & Renhua Fan. (2021) Advances in the development of HIV integrase strand transfer inhibitors. European Journal of Medicinal Chemistry 225, pages 113787.
Crossref
Crossref
Lamya H. Al-Wahaibi, Sai Ramya Sree Bysani, Samar S. Tawfik, Mohammed S. M. Abdelbaky, Santiago Garcia-Granda, Ali A. El-Emam, M. Judith Percino & Subbiah Thamotharan. (2021) Invariant and Variable Supramolecular Self-Assembly in 6-Substituted Uracil Derivatives: Insights from X-ray Structures and Quantum Chemical Study. Crystal Growth & Design 21:6, pages 3234-3250.
Crossref
Crossref
Nokuzola Mbhele, Benjamin Chimukangara & Michelle Gordon. (2021) HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance. International Journal of Antimicrobial Agents 57:5, pages 106343.
Crossref
Crossref
Neetu Jabalia, Atul Kumar, Vinit Kumar & Reshma Rani. 2021. Innovations and Implementations of Computer Aided Drug Discovery Strategies in Rational Drug Design. Innovations and Implementations of Computer Aided Drug Discovery Strategies in Rational Drug Design
245
271
.
Leïla Belkhir, Carole Seguin-Devaux, Laure Elens, Caroline Pauly, Nicolas Gengler, Serge Schneider, Jean Ruelle, Vincent Haufroid & Bernard Vandercam. (2018) Impact of UGT1A1 polymorphisms on Raltegravir and its glucuronide plasma concentrations in a cohort of HIV-1 infected patients. Scientific Reports 8:1.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
687
736
.
Rahul V. Patel, Young-Soo Keum & Se Won Park. (2015) Sketching the historical development of pyrimidones as the inhibitors of the HIV integrase. European Journal of Medicinal Chemistry 97, pages 649-663.
Crossref
Crossref
Yue-Xia Bai, Long-Ji Li, Xiao-Li Wang, Cheng-Chu Zeng & Li-Ming Hu. (2014) Design and synthesis of N-hydroxytriazole-4-carboxamides as HIV integrase inhibitors. Medicinal Chemistry Research 24:1, pages 423-429.
Crossref
Crossref
Wan-Gang Gu. (2014) Newly approved integrase inhibitors for clinical treatment of AIDS. Biomedicine & Pharmacotherapy 68:8, pages 917-921.
Crossref
Crossref
Roberto Di Santo. (2013) Inhibiting the HIV Integration Process: Past, Present, and the Future. Journal of Medicinal Chemistry 57:3, pages 539-566.
Crossref
Crossref
Vasanthanathan Poongavanam, N. S. Hari Narayana Moorthy & Jacob Kongsted. (2014) Dual mechanism of HIV-1 integrase and RNase H inhibition by diketo derivatives ? a computational study. RSC Adv. 4:73, pages 38672-38681.
Crossref
Crossref
M. Van Loock, A. Hombrouck, T. Jacobs, B. Winters, G. Meersseman, K. Van Acker, R.F. Clayton & B.A. Malcolm. (2013) Reporter gene expression from LTR-circles as tool to identify HIV-1 integrase inhibitors. Journal of Virological Methods 187:2, pages 238-247.
Crossref
Crossref
Serena Fortuna, Massimiliano Fabbiani, Simona Digiambenedetto, Enzo Ragazzoni, Lucia Lisi, Roberto Cauda & Pierluigi Navarra. (2013) Variability of Raltegravir Plasma Levels in the Clinical Setting. Pharmacology 92:1-2, pages 43-48.
Crossref
Crossref
Xue Zhi Zhao, Kasthuraiah Maddali, Mathieu Metifiot, Steven J. Smith, B. Christie Vu, Christophe Marchand, Stephen H. Hughes, Yves Pommier & Terrence R. BurkeJrJr. (2012) Bicyclic Hydroxy-1H-pyrrolopyridine-trione Containing HIV-1 Integrase Inhibitors. Chemical Biology & Drug Design 79:2, pages 157-165.
Crossref
Crossref
Antonio Piralla, Stefania Paolucci, Roberto Gulminetti, Giuditta Comolli & Fausto Baldanti. (2011) HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients. Virology Journal 8:1.
Crossref
Crossref
Chenzhong Liao & Marc C. Nicklaus. 2011. HIV‐1 Integrase. HIV‐1 Integrase
429
455
.
Olivia Goethals, Marcia Van Ginderen, Ann Vos, Maxwell D. Cummings, Koen Van Der Borght, Liesbeth Van Wesenbeeck, Maxim Feyaerts, Ann Verheyen, Veerle Smits, Marnix Van Loock, Kurt Hertogs, Dominique Schols & Reginald F. Clayton. (2011) Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitor. Antiviral Research 91:2, pages 167-176.
Crossref
Crossref
Ted W. Johnson, Steven P. Tanis, Scott L. Butler, Deepak Dalvie, Dorothy M. DeLisle, Klaus R. Dress, Erik J. Flahive, Qiyue Hu, Jon E. Kuehler, Atsuo Kuki, Wen Liu, Guy A. McClellan, Qinghai Peng, Michael B. Plewe, Paul F. Richardson, Graham L. Smith, Jim Solowiej, Khanh T. Tran, Hai Wang, Xiaoming Yu, Junhu Zhang & Huichun Zhu. (2011)
Design and Synthesis of Novel
N
-Hydroxy-Dihydronaphthyridinones as Potent and Orally Bioavailable HIV-1 Integrase Inhibitors
. Journal of Medicinal Chemistry 54:9, pages 3393-3417.
Crossref
Crossref
Steven P. Tanis, Michael B. Plewe, Ted W. Johnson, Scott L. Butler, Deepak Dalvie, Dorothy DeLisle, Klaus R. Dress, Qiyue Hu, Buwen Huang, Jon E. Kuehler, Atsuo Kuki, Wen Liu, Qinghai Peng, Graham L. Smith, Jim Solowiej, Khanh T. Tran, Hai Wang, Anle Yang, Chunfeng Yin, Xiaoming Yu, Junhu Zhang & Huichun Zhu. (2010) Azaindole N-methyl hydroxamic acids as HIV-1 integrase inhibitors-II. The impact of physicochemical properties on ADME and PK. Bioorganic & Medicinal Chemistry Letters 20:24, pages 7429-7434.
Crossref
Crossref
Zixin Hu & Daniel R Kuritzkes. (2010) Effect of Raltegravir Resistance Mutations in HIV-1 Integrase on Viral Fitness. JAIDS Journal of Acquired Immune Deficiency Syndromes 55:2, pages 148-155.
Crossref
Crossref
Donald J. AbrahamBrian A. Johns. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
75
106
.
James M. Smith, Allison Dauner, Bin Li, Priya Srinivasan, James Mitchell, Michael Hendry, Dennis Ellenberger, Sal Butera & Ron A. Otten. (2010) Generation of a dual RT Env SHIV that is infectious in rhesus macaques. Journal of Medical Primatology 39:4, pages 213-223.
Crossref
Crossref
Chenzhong Liao, Christophe Marchand, Terrence R Burke Jr, Yves Pommier & Marc C Nicklaus. (2010) Authentic HIV-1 integrase inhibitors. Future Medicinal Chemistry 2:7, pages 1107-1122.
Crossref
Crossref
Chenzhong Liao & Marc C Nicklaus. (2010) Computer tools in the discovery of HIV-1 integrase inhibitors. Future Medicinal Chemistry 2:7, pages 1123-1140.
Crossref
Crossref
Olivia Goethals, Ann Vos, Marcia Van Ginderen, Peggy Geluykens, Veerle Smits, Dominique Schols, Kurt Hertogs & Reginald Clayton. (2010) Primary mutations selected in vitro with raltegravir confer large fold changes in susceptibility to first-generation integrase inhibitors, but minor fold changes to inhibitors with second-generation resistance profiles. Virology 402:2, pages 338-346.
Crossref
Crossref
Filippo Canducci, Maria Chiara Marinozzi, Michela Sampaolo, Enzo Boeri, Vincenzo Spagnuolo, Nicola Gianotti, Antonella Castagna, Stefania Paolucci, Fausto Baldanti, Adriano Lazzarin & Massimo Clementi. (2010) Genotypic/phenotypic patterns of HIV-1 integrase resistance to raltegravir. Journal of Antimicrobial Chemotherapy 65:3, pages 425-433.
Crossref
Crossref
Brian A. Johns. 2010.
262
276
.
Michael B. Plewe, Scott L. ButlerKlaus R. Dress, Qiyue Hu, Ted W. Johnson, Jon E. Kuehler, Atsuo Kuki, Hieu Lam, Wen Liu, Dawn Nowlin, Qinghai Peng, Sadayappan V. Rahavendran, Steven P. Tanis, Khanh T. Tran, Hai Wang, Anle Yang & Junhu Zhang. (2009) Azaindole Hydroxamic Acids are Potent HIV-1 Integrase Inhibitors. Journal of Medicinal Chemistry 52:22, pages 7211-7219.
Crossref
Crossref
Christina Gavegnano & Raymond F Schinazi. (2009) Antiretroviral Therapy in Macrophages: Implication for HIV Eradication. Antiviral Chemistry and Chemotherapy 20:2, pages 63-78.
Crossref
Crossref
Xue Zhi Zhao, Kasthuraiah Maddali, Christophe Marchand, Yves Pommier & Terrence R. BurkeJr.Jr.. (2009) Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionality. Bioorganic & Medicinal Chemistry 17:14, pages 5318-5324.
Crossref
Crossref
. (2009) Ce qu’il faut retenir sur l’actualité thérapeutique des antirétroviraux. Actualités Pharmaceutiques 48:485, pages 19.
Crossref
Crossref
Devendra K. Dhaked, Jitender Verma, Anil Saran & Evans C. Coutinho. (2008) Exploring the binding of HIV-1 integrase inhibitors by comparative residue interaction analysis (CoRIA). Journal of Molecular Modeling 15:3, pages 233-245.
Crossref
Crossref
C. Katlama, R. Tubiana & R. Murphy. (2009) Les nouvelles molécules anti-VIH : la place du raltégravir. Antibiotiques 11:1, pages 11-17.
Crossref
Crossref
Christoph BoeseckeLinda Gelgor. (2009) A Review of Raltegravir and its Use in HIV-1 Infection. Clinical Medicine. Therapeutics 1, pages CMT.S1985.
Crossref
Crossref
Olivia Goethals, Reginald Clayton, Marcia Van Ginderen, Inge Vereycken, Elisabeth Wagemans, Peggy Geluykens, Koen Dockx, Rudy Strijbos, Veerle Smits, Ann Vos, Geert Meersseman, Dirk Jochmans, Kurt Vermeire, Dominique Schols, Sabine Hallenberger & Kurt Hertogs. (2008) Resistance Mutations in Human Immunodeficiency Virus Type 1 Integrase Selected with Elvitegravir Confer Reduced Susceptibility to a Wide Range of Integrase Inhibitors. Journal of Virology 82:21, pages 10366-10374.
Crossref
Crossref
Kazuya ShimuraEiichi Kodama. (2008) Elvitegravir: an emerging HIV integrase inhibitor. Future HIV Therapy 2:5, pages 411-418.
Crossref
Crossref
Masaaki Takahashi, Mitsuru Konishi, Yuichi Kudaka, Naoya Okumura, Atsushi Hirano, Nami Terahata, Kazuhide Banno & Tsuguhiro Kaneda. (2008) A Conventional LC-MS Method Developed for the Determination of Plasma Raltegravir Concentrations. Biological & Pharmaceutical Bulletin 31:8, pages 1601-1604.
Crossref
Crossref
Shridhar Hegde & Michelle Schmidt. 2008.
455
497
.